Rare and Fatal Gastrointestinal Mucormycosis (Zygomycosis) in a COVID-19 Patient: A Case Report
Epifanio Silvino do Monte Junior, Marcos Eduardo Lera dos Santos, Igor Braga Ribeiro, Gustavo de Oliveira Luz, Elisa Ryoka Baba, Bruno Salomão Hirsch, Mateus Pereira Funari, Eduardo Guimarães Hourneaux de Moura
Clin Endosc 2020;53(6):746-749.   Published online 2020 Nov 19     DOI: https://doi.org/10.5946/ce.2020.180
Citations to this article as recorded by Crossref logo
The potential for rapid antigen testing for mucormycosis in the context of COVID-19
Christopher R. Thornton
Expert Review of Molecular Diagnostics.2024; 24(3): 161.     CrossRef
A New Proposed Combined CT and MRI Staging System for Covid-19-Associated Rhino-Orbito-Cerebral Fungal Infection: A Multi-center Study with Pathological Correlation
Noha Yahia Ebaid, Haitham Foda, Doaa Khedr Mohamed Khedr, Ahmed Ebeed, Mahmoud Ahmed Ebada, Rabab Mohamed Abdelhay, Ali Awad, Amany Abd Al Badea, Basma Hamed Ibrahim, Emad Hassan Emara
Academic Radiology.2024; 31(3): 1055.     CrossRef
Development of a machine learning model to predict risk of development of COVID-19-associated mucormycosis
Rajashri Patil, Sahjid Mukhida, Jyoti Ajagunde, Uzair Khan, Sameena Khan, Nageswari Gandham, Chanda Vyawhare, Nikunja K Das, Shahzad Mirza
Future Microbiology.2024; 19(4): 297.     CrossRef
COVID-19 Second Wave with Mucormycosis, a Deadly Combination: A Systemic Review
Neetu Jain, Seema Bhadauria
Biomedical and Biotechnology Research Journal.2024; 8(1): 13.     CrossRef
The cross-talk between mucormycosis, steroids and diabetes mellitus amidst the global contagion of COVID-19
Shrey Dwivedi, Princy Choudhary, Ayushi Gupta, Sangeeta Singh
Critical Reviews in Microbiology.2023; 49(3): 318.     CrossRef
Magnetic resonance imaging spectrum of COVID-associated rhino-orbital-cerebral mucormycosis and assessment of anatomical severity
Ishan Kumar, Ashish Verma, Jyoti Dangwal, Pramod Kumar Singh, Ram Chandra Shukla, Jaya Chakravarty
The Neuroradiology Journal.2023; 36(4): 404.     CrossRef
Mucormycosis and Its Upsurge During COVID-19 Epidemic: An Updated Review
Bharti Sharma, Skarma Nonzom
Current Microbiology.2023;[Epub]     CrossRef
Mucormycosis: A hidden mystery of fungal infection, possible diagnosis, treatment and development of new therapeutic agents
Mohd Kamil Hussain, Shaista Ahmed, Andleeb Khan, Arif Jamal Siddiqui, Shahnaaz Khatoon, Sadaf Jahan
European Journal of Medicinal Chemistry.2023; 246: 115010.     CrossRef
cotH Genes Are Necessary for Normal Spore Formation and Virulence in Mucor lusitanicus
Csilla Szebenyi, Yiyou Gu, Teclegiorgis Gebremariam, Sándor Kocsubé, Sándor Kiss-Vetráb, Olivér Jáger, Roland Patai, Krisztina Spisák, Rita Sinka, Ulrike Binder, Mónika Homa, Csaba Vágvölgyi, Ashraf S. Ibrahim, Gábor Nagy, Tamás Papp, Anuradha Chowdhary
mBio.2023;[Epub]     CrossRef
Post COVID-19: Risk Factors, Prevention, and Management of Black Fungus
Aimen Salman, Suneela Dhaneshwar, Shaik Shafiulla
Anti-Infective Agents.2023; 21(1): 39.     CrossRef
Surge of mucormycosis during the COVID-19 pandemic
Paulami Dam, Marlon H. Cardoso, Sukhendu Mandal, Octávio L. Franco, Pınar Sağıroğlu, Osman Ahmet Polat, Kerem Kokoglu, Rittick Mondal, Amit Kumar Mandal, Ismail Ocsoy
Travel Medicine and Infectious Disease.2023; 52: 102557.     CrossRef
COVID-19 and Mucormycosis of Orofacial Region: A Scoping Review
Abhishek Banerjee, Moumalini Das, Pooja Verma, Abhishek Chatterjee, Karthikeyan Ramalingam, Kumar Chandan Srivastava
Cureus.2023;[Epub]     CrossRef
Case Reports on Black Fungus of the Gastrointestinal Tract: A New Complication in COVID-19 Patients
Sachin Arora, Ashish Singh, Pallavi Prasad, Rahul, Rajneesh Singh
The Korean Journal of Gastroenterology.2023; 81(5): 221.     CrossRef
Galangin for COVID-19 and Mucormycosis co-infection: a potential therapeutic strategy of targeting critical host signal pathways triggered by SARS-CoV-2 and Mucormycosis
Md. Imran Hasan, Md. Arju Hossain, Md Habibur Rahman, Md Sohel, Asif Ahsan, Md. Sadat Hossain Soikot, Md. Nazrul Islam, Mohammad Ruhul Amin, Deepak Kumar Jain
Network Modeling Analysis in Health Informatics and Bioinformatics.2023;[Epub]     CrossRef
Opportunistic Fungal Invasion in COVID-19 Pandemic: A Critical Review in Diagnosis and Management
Abhishek Sharma, Gulnaz Bano, Abdul Malik, Yuman Rasool, Samrina Manzar, Tarun Singh, Manish Maity
Avicenna Journal of Medicine.2023; 13(03): 131.     CrossRef
Effect of antifungal drugs against mucormycosis and impact on human health
Shivangi Giri, Sujata Sharma, Kumud Kant Awasthi, Lata Shahani
Materials Today: Proceedings.2023; 95: 43.     CrossRef
Epidemiology, Risk Factors, Diagnosis and Treatment of Mucormycosis (Black Fungus): A Review
Pragati Upadhayay, Keshav Bansal, Ahsas Goyal
Current Pharmaceutical Biotechnology.2023; 24(13): 1645.     CrossRef
View of mucormycosis during the era of COVID-19 infection: A cross-sectional study
Ossama M. Zakaria, Dana W. Alkuwaity
Journal of Family Medicine and Primary Care.2023; 12(11): 2608.     CrossRef
An Update on COVID‐19 Associated Mucormycosis Characteristics, Risk Factors, and Outcomes: a Systematic Review and Meta-Analysis
Kazem Khiabani, Mohammad Hosein Amirzade-Iranaq, Hanie Ahmadi
Current Fungal Infection Reports.2023; 17(4): 282.     CrossRef
CT Findings of COVID-19–associated Pulmonary Mucormycosis: A Case Series and Literature Review
Mandeep Garg, Nidhi Prabhakar, Valliappan Muthu, Shameema Farookh, Harsimran Kaur, Vikas Suri, Ritesh Agarwal
Radiology.2022; 302(1): 214.     CrossRef
Mucormycosis (black fungus) ensuing COVID-19 and comorbidity meets - Magnifying global pandemic grieve and catastrophe begins
Karthika Pushparaj, Haripriya Kuchi Bhotla, Vijaya Anand Arumugam, Manikantan Pappusamy, Murugesh Easwaran, Wen-Chao Liu, Utthapon Issara, Kannan R.R. Rengasamy, Arun Meyyazhagan, Balamuralikrishnan Balasubramanian
Science of The Total Environment.2022; 805: 150355.     CrossRef
Mucormycosis: A Case Series of Patients Admitted in Non-COVID-19 Intensive Care Unit of a Tertiary Care Center during the Second Wave
Nikhil Kothari, Amit Goyal, Ankur Sharma, Shilpa Goyal, Pradeep K Bhatia, Sangam Yadav
Indian Journal of Critical Care Medicine.2022; 25(10): 1193.     CrossRef
A systematic review on SARS‐CoV‐2‐associated fungal coinfections
Shringika Soni, Ramesh Namdeo Pudake, Utkarsh Jain, Nidhi Chauhan
Journal of Medical Virology.2022; 94(1): 99.     CrossRef
Rhino-orbito-cerebral mucormycosis during the COVID-19 third wave in 2021: an Egyptian preliminary report from a single tertiary hospital
Taha K. Alloush, Osama Mansour, Adel T. Alloush, Tamer Roushdy, Eman Hamid, Mahmoud El-Shamy, Hossam M. Shokri
Neurological Sciences.2022; 43(2): 799.     CrossRef
Cumulative Mortality and Factors Associated With Outcomes of Mucormycosis After COVID-19 at a Multispecialty Tertiary Care Center in India
Twinkle Choksi, Anamika Agrawal, Purva Date, Darshana Rathod, Anuja Gharat, Avinash Ingole, Bhushan Chaudhari, Nitin Pawar
JAMA Ophthalmology.2022; 140(1): 66.     CrossRef
Using artificial intelligence-based models to predict the risk of mucormycosis among COVID-19 survivors: An experience from a public hospital in India
Shabbir Syed-Abdul, A. Shoban Babu, Raja Shekhar Bellamkonda, Ramaiah Itumalla, GVRK Acharyulu, Surya Krishnamurthy, Y. Venkat Santosh Ramana, Naresh Mogilicharla, Shwetambara Malwade, Yu-Chuan Li
Journal of Infection.2022; 84(3): 351.     CrossRef
Bilateral Renal Mucor Mycosis Presenting as Anuria in a Covid 19 Recovered Patient: A Case Report and Review of Literature
Surya Prakash Vaddi, Seshu Mohan Khetavath, Dilip M. Babu, Nagarjuna Maturu, Bhulaxmi, Swathi, Krithika Mohan, Datta Prasad M, Jawahar B, Rajesh Reddy KRV
Urology.2022; 161: 12.     CrossRef
Fungal Infections Other Than Invasive Aspergillosis in COVID-19 Patients
Kerri Basile, Catriona Halliday, Jen Kok, Sharon C-A. Chen
Journal of Fungi.2022; 8(1): 58.     CrossRef
Gastrointestinal mucormycosis: A periodic systematic review of case reports from 2015 to 2021
Mojtaba Didehdar, Zahra chegini, Alireza Moradabadi, Ali Arash Anoushirvani, Seidamir Pasha Tabaeian, Milad Yousefimashouf, Aref Shariati
Microbial Pathogenesis.2022; 163: 105388.     CrossRef
Gastrointestinal Mucormycosis: A Challenge during COVID-19 Pandemic
Jagdish Chander
Journal of Gastrointestinal Infections.2022; 11(1): 30.     CrossRef
COVID-19 associated mucormycosis – An emerging threat
Chien-Ming Chao, Chih-Cheng Lai, Wen-Liang Yu
Journal of Microbiology, Immunology and Infection.2022; 55(2): 183.     CrossRef
The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries
Martin Hoenigl, Danila Seidel, Agostinho Carvalho, Shivaprakash M Rudramurthy, Amir Arastehfar, Jean-Pierre Gangneux, Nosheen Nasir, Alexandro Bonifaz, Javier Araiza, Nikolai Klimko, Alexandra Serris, Katrien Lagrou, Jacques F Meis, Oliver A Cornely, John
The Lancet Microbe.2022; 3(7): e543.     CrossRef
Fatal allograft mucormycosis complicating severe COVID‐19 infection and bacterial pyelonephritis
Abhilash Chandra, Namrata Rao S., Kiran Preet Malhotra
Transplant Infectious Disease.2022;[Epub]     CrossRef
Mucormycosis in COVID-19 pandemic: study at tertiary hospital in India
Reshma P. Chavan, Shivraj M. Ingole, Hamna Abdul Nazir, Wilson V. Desai, Gajanan S. Kanchewad
European Archives of Oto-Rhino-Laryngology.2022; 279(6): 3201.     CrossRef
Mucormycosis and COVID-19 pandemic: Clinical and diagnostic approach
Asim Azhar, Wajihul Hasan Khan, Parvez Anwar Khan, Khaled Alhosaini, Mohammad Owais, Aijaz Ahmad
Journal of Infection and Public Health.2022; 15(4): 466.     CrossRef
COVID19 associated mucormycosis: A review
PriyadharsiniR Palanisamy, Dhivya Elango
Journal of Family Medicine and Primary Care.2022; 11(2): 418.     CrossRef
Mucormycosis: risk factors, diagnosis, treatments, and challenges during COVID-19 pandemic
Ayushi Sharma, Anjana Goel
Folia Microbiologica.2022; 67(3): 363.     CrossRef
Retracted: Mucormycosis infection in patients with COVID‐19: A systematic review
SeyedAhmad SeyedAlinaghi, Amirali Karimi, Alireza Barzegary, Zahra Pashaei, Amir Masoud Afsahi, Sanam Alilou, Nazanin Janfaza, Alireza Shojaei, Fatemeh Afroughi, Parsa Mohammadi, Yasna Soleimani, Newsha Nazarian, Ava Amiri, Marcarious M. Tantuoyir, Shahra
Health Science Reports.2022;[Epub]     CrossRef
Epidemiology, clinical presentation and management of COVID‐19 associated mucormycosis: A single centre experience from Pune, Western India
Ameet Dravid, Reema Kashiva, Zafer Khan, Balasaheb Bande, Danish Memon, Aparna Kodre, Milind Mane, Vishal Pawar, Dattatraya Patil, Suraj Kalyani, Prathamesh Raut, Madhura Bapte, Charlotte Saldanha, Dinesh Chandak, Teerthagouda Patil, Sateesh Reddy, Krushn
Mycoses.2022; 65(5): 526.     CrossRef
Rhino-Orbital-Cerebral Mucormycosis in a Post-COVID-19 Patient from Peru
Linda Ponce-Rosas, Jose Gonzales-Zamora, Nelson Diaz-Reyes, Oliver Alarco-Cadillo, Jorge Alave-Rosas, Mohd Adnan
Case Reports in Infectious Diseases.2022; 2022: 1.     CrossRef
Mucormycosis: A Lethal Disease
Pawan N. Karwa, Jyoti K. Soundarmal, Pallavi S. Shinde, Swapna R. Jalde
Asian Journal of Pharmacy and Technology.2022; : 41.     CrossRef
An overview of COVID-19 related to fungal infections: what do we know after the first year of pandemic?
R. G. Vitale, J. Afeltra, S. Seyedmousavi, S. L. Giudicessi, S. M. Romero
Brazilian Journal of Microbiology.2022; 53(2): 759.     CrossRef
Mucormycosis: A new threat to Coronavirus disease 2019 with special emphasis on India
Deganta Ghosh, Sagardeep Dey, Himanko Chakraborty, Sneha Mukherjee, Ankita Halder, Akash Sarkar, Pallab Chakraborty, Rajdeep Ghosh, Joy Sarkar
Clinical Epidemiology and Global Health.2022; 15: 101013.     CrossRef
First Reported Cases of COVID-19-Associated Mucormycosis in Tunisia
Rim Khemakhem, Ichrak Bougharriou, Nesrine Kallel, Anis Bafoun, Feten Mahmoudi, Samy Kammoun
Electronic Journal of Medical and Dental Studies.2022; 12(1): em0097.     CrossRef
Iranian patients co-infected with COVID-19 and mucormycosis: the most common predisposing factor, clinical outcomes, laboratory markers and diagnosis, and drug therapies
Hamideh Molaei, Ehsan Shojaeefar, Eghlim Nemati, Leila Khedmat, Sayed Yousef Mojtahedi, Nematollah Jonaidi Jafari, Morteza Izadi, Behzad Einollahi
Infectious Diseases.2022; 54(8): 600.     CrossRef
COVID-19 and Plethora of Fungal Infections
Reetu Kundu, Nidhi Singla
Current Fungal Infection Reports.2022; 16(2): 47.     CrossRef
A Comprehensive Review on the Management of COVID-19-Associated Mucormycosis (CAM): The New Basics
Divyam Girdhar, Ekta Manocha
BioMed.2022; 2(2): 181.     CrossRef
Mucormycosis and COVID-19-Associated Mucormycosis: Insights of a Deadly but Neglected Mycosis
Laura C. García-Carnero, Héctor M. Mora-Montes
Journal of Fungi.2022; 8(5): 445.     CrossRef
COVID-19-Associated Fungal Infections: An Urgent Need for Alternative Therapeutic Approach?
Marianna Domán, Krisztián Bányai
Frontiers in Microbiology.2022;[Epub]     CrossRef
Current Treatment Options for COVID-19 Associated Mucormycosis: Present Status and Future Perspectives
Yasasve Madhavan, Kadambari Vijay Sai, Dilip Kumar Shanmugam, Aashabharathi Manimaran, Karthigadevi Guruviah, Yugal Kishore Mohanta, Divyambika Catakapatri Venugopal, Tapan Kumar Mohanta, Nanaocha Sharma, Saravanan Muthupandian
Journal of Clinical Medicine.2022; 11(13): 3620.     CrossRef
Fungal Infection in Co-infected Patients With COVID-19: An Overview of Case Reports/Case Series and Systematic Review
Sima Sadat Seyedjavadi, Parmida Bagheri, Mohammad Javad Nasiri, Mehdi Razzaghi-Abyaneh, Mehdi Goudarzi
Frontiers in Microbiology.2022;[Epub]     CrossRef
COVID-19-associated fungal infections in Iran: A systematic review
Tina Nazari, Fatemeh Sadeghi, Alireza Izadi, Setayesh Sameni, Shahram Mahmoudi, Felix Bongomin
PLOS ONE.2022; 17(7): e0271333.     CrossRef
Effect of Indoor Bioaerosols (Fungal) Exposure on the Health of Post-COVID-19 Patients and Possible Mitigation Strategies
Yogesh Kumar Vishwakarma, Amrita Shahi, Ram Sharan Singh
COVID.2022; 2(7): 940.     CrossRef
Mucormycosis in patients with COVID-19 in Russia: the results of a prospective multi-center study
S. N. Khostelidi, V. A. Zaytsev, S. A. Vartanyan, N. A. Nikitin, G. N. Evtukh, M. N. Gilalov, G. V. Portnov, A. A. Zubareva, I. B. Baranova, T. S. Bogomolova, Yu. L. Avdeenko, O. V. Shadrivova, E. A. Desyatik, E. V. Shagdileeva, Yu. V. Borzova, Yu. A. Kri
Journal Infectology.2022; 14(2): 116.     CrossRef
Development of a Monoclonal Antibody and a Serodiagnostic Lateral-Flow Device Specific to Rhizopus arrhizus (Syn. R. oryzae), the Principal Global Agent of Mucormycosis in Humans
Genna E. Davies, Christopher R. Thornton
Journal of Fungi.2022; 8(7): 756.     CrossRef
Mucormycosis co-infection in COVID-19 patients: An update
Abdullah S. Alkhamiss, Ahmed A. Ahmed, Zafar Rasheed, Ruqaih Alghsham, Ali Shariq, Thamir Alsaeed, Sami A. Althwab, Suliman Alsagaby, Abdullah S. M. Aljohani, Fahad A. Alhumaydhi, Sharifa K. Alduraibi, Alaa K. Alduraibi, Homaidan T. Alhomaidan, Khaled S.
Open Life Sciences.2022; 17(1): 917.     CrossRef
COVID-19-Associated Mucormycosis: A Matter of Concern Amid the SARS-CoV-2 Pandemic
Pankaj Chandley, Priyanka Subba, Soma Rohatgi
Vaccines.2022; 10(8): 1266.     CrossRef
Antifungal therapy in the management of fungal secondary infections in COVID-19 patients: A systematic review and meta-analysis
Sujit Kumar Sah, Atiqulla Shariff, Niharika Pathakamuri, Subramanian Ramaswamy, Madhan Ramesh, Krishna Undela, Malavalli Siddalingegowda Srikanth, Teggina Math Pramod Kumar, Joy Sturtevant
PLOS ONE.2022; 17(7): e0271795.     CrossRef
The role of SARS-CoV-2 immunosuppression and the therapy used to manage COVID-19 disease in the emergence of opportunistic fungal infections: A review
Nahid Akhtar, Atif Khurshid Wani, Surya Kant Tripathi, Ajit Prakash, M. Amin-ul Mannan
Current Research in Biotechnology.2022; 4: 337.     CrossRef
Mortality-Related Risk Factors for Coronavirus Disease (COVID-19)-Associated Mucormycosis: a systematic review and meta-analysis
Vahid Reza Ostovan, Reza Tabrizi, Hanieh Bazrafshan, Zahra Bahrami, Hajar Khazraei, Samaneh Khazraei, Afshin Borhani-Haghighi, Mohsen Moghadami, Matthew Grant
Current Fungal Infection Reports.2022; 16(4): 143.     CrossRef
Comparative risk assessment of COVID‐19 associated mucormycosis and aspergillosis: A systematic review
Prodip Kumar Baral, Md. Abdul Aziz, Mohammad Safiqul Islam
Health Science Reports.2022;[Epub]     CrossRef
COVID-19 and Fungal infections: a double debacle
Sara Mina, Hajar Yaakoub, Cédric Annweiler, Vincent Dubée, Nicolas Papon
Microbes and Infection.2022; 24(8): 105039.     CrossRef
Wave of Invasive Fungal Disease on the Shores of COVID-19: A Case Series of COVID-19 Associated Rhino-Orbital Fungal Rhinosinusitis and Literature Review
Sandeep Trehan, Neena Chaudhary, Ashwin Bhasarkar
Indian Journal of Otolaryngology and Head & Neck Surgery.2022; 74(S2): 3359.     CrossRef
A study of rhino-orbito-cerebral mucormycosis with COVID-19: A new challenge in North West of Rajasthan
Surendra Kumar, Harish Kumar, Manoj Mali, BabuLal Meena
Annals of African Medicine.2022; 21(4): 383.     CrossRef
Is the production of reactive oxygen and nitrogen species by macrophages associated with better infectious control in female mice with experimentally disseminated and pulmonary mucormycosis?
Amanda Ribeiro dos Santos, Thais Fernanda Fraga-Silva, Débora de Fátima Almeida-Donanzam, Angela Carolina Finatto, Camila Marchetti, Maria Izilda Andrade, Olavo Speranza de Arruda, Maria Sueli Parreira de Arruda, James Venturini, Michal A Olszewski
PLOS ONE.2022; 17(12): e0270071.     CrossRef
Mucormycosis, COVID-19 Pandemic and the Lessons Learnt: A Review
Anila Varghese, Anita Upadhyay, RoyA Daniel, Twinkle Sharma, MShyam Mohan, Balaji Susindran, Priyanka Singh, Chandrakant Lahariya
Journal of Medical Evidence.2022; 3(3): 256.     CrossRef
Gastritis enfisematosa secundaria a mucormicosis gástrica en paciente con COVID-19. Reporte de un caso
Martín Islas Torres, Ana Laura Castillo Luna, José Juan Rodríguez Moreno, Valeria Priscilla Rendón Muñoz, José Gerardo Zamora Inzuna, Albert Antonio Ibarra Trejo
Cirujano General.2022; 44(2): 87.     CrossRef
A Fatal Case of Rhizopus azygosporus Pneumonia Following COVID-19
Anubhav Kanwar, Alex Jordan, Scott Olewiler, Kurt Wehberg, Michael Cortes, Brendan R. Jackson
Journal of Fungi.2021; 7(3): 174.     CrossRef
The double‐edged sword of systemic corticosteroid therapy in viral pneumonia: A case report and comparative review of influenza‐associated mucormycosis versus COVID‐19 associated mucormycosis
Kazem Ahmadikia, Seyed Jamal Hashemi, Sadegh Khodavaisy, Muhammad Ibrahim Getso, Neda Alijani, Hamid Badali, Hossein Mirhendi, Mohammadreza Salehi, Azin Tabari, Mojtaba Mohammadi Ardehali, Mohammad Kord, Emmanuel Roilides, Sassan Rezaie
Mycoses.2021; 64(8): 798.     CrossRef
Antibacterials/hydrocortisone/oseltamivir
Reactions Weekly.2021; 1845(1): 43.     CrossRef
Mucormycosis after Coronavirus disease 2019 infection in a heart transplant recipient – Case report and review of literature
Akshay Khatri, Kai-Ming Chang, Ilan Berlinrut, Frances Wallach
Journal of Medical Mycology.2021; 31(2): 101125.     CrossRef
Research and Management of Rare Diseases in the COVID-19 Pandemic Era: Challenges and Countermeasures
Sanjana Fatema Chowdhury, Syed Muktadir Al Sium, Saeed Anwar
Frontiers in Public Health.2021;[Epub]     CrossRef
Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India
Awadhesh Kumar Singh, Ritu Singh, Shashank R. Joshi, Anoop Misra
Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2021; 15(4): 102146.     CrossRef
Rhinocerebral mucormycosis in COVID-19 patient with diabetes a deadly trio: Case series from the north-western part of India
Hardeva Ram Nehara, Inder Puri, Vipin Singhal, Sunil IH, Bhagirath Ram Bishnoi, Pramendra Sirohi
Indian Journal of Medical Microbiology.2021; 39(3): 380.     CrossRef
COVID 19 infection and mucormycosis—a dangerously increasing combination
Satvinder Singh Bakshi, Vinoth Kumar Kalidoss
The Egyptian Journal of Otolaryngology.2021;[Epub]     CrossRef
Autoptic identification of disseminated mucormycosis in a young male presenting with cerebrovascular event, multi-organ dysfunction and COVID-19 infection
Vidya Krishna, Jaymin Morjaria, Rona Jalandari, Fatima Omar, Sundeep Kaul
IDCases.2021; 25: e01172.     CrossRef
Does COVID 19 generate a milieu for propagation of mucormycosis?
Deepak Pandiar, N. Siva Kumar, Rahul Anand, Mala Kamboj, Anjali Narwal, P.M. Shameena
Medical Hypotheses.2021; 152: 110613.     CrossRef
Mucormycosis associated with COVID‐19 in two kidney transplant patients
Carolt Arana, Rafael E. Cuevas Ramírez, Marc Xipell, Joaquim Casals, Asunción Moreno, Sabina Herrera, Marta Bodro, Frederic Cofan, Fritz Diekmann, Núria Esforzado
Transplant Infectious Disease.2021;[Epub]     CrossRef
COVID-19 associated mucormycosis: the urgent need to reconsider the indiscriminate use of immunosuppressive drugs
Alfonso J. Rodriguez-Morales, Ranjit Sah, Jose Millan-Oñate, Angel Gonzalez, Juan J. Montenegro-Idrogo, Sias Scherger, Carlos Franco-Paredes, Andrés F. Henao-Martínez
Therapeutic Advances in Infectious Disease.2021; 8: 204993612110270.     CrossRef
COVID‐19‐associated mucormycosis: An updated systematic review of literature
Rimesh Pal, Birgurman Singh, Sanjay Kumar Bhadada, Mainak Banerjee, Ranjitpal Singh Bhogal, Neemu Hage, Ashok Kumar
Mycoses.2021; 64(12): 1452.     CrossRef
Rare case of gastrointestinal mucormycosis with colonic perforation in an immunocompetent patient with COVID-19
Ravinder Pal Singh, Nishkarsh Gupta, Tanudeep Kaur, Anju Gupta
BMJ Case Reports.2021; 14(7): e244096.     CrossRef
The double trouble: COVID-19 associated mucormycosis a focused review and future perspectives
Arun Kumar Agnihotri, Monika Vij, Okezie I. Aruoma, Vipul D Yagnik, Theeshan Bahorun, Maria Elena Villamil, Godfred A. Menezes, Vineet Gupta
Global Journal of Medical, Pharmaceutical, and Biomedical Update.2021; 16: 4.     CrossRef
Mucormycosis: An opportunistic pathogen during COVID-19
Iyer Mahalaxmi, Kaavya Jayaramayya, Dhivya Venkatesan, Mohana Devi Subramaniam, Kaviyarasi Renu, Padmavathi Vijayakumar, Arul Narayanasamy, Abilash Valsala Gopalakrishnan, Nachimuthu Senthil Kumar, Palanisamy Sivaprakash, Krothapalli R.S. Sambasiva Rao, B
Environmental Research.2021; 201: 111643.     CrossRef
Epidemiology of Systemic Mycoses in the COVID-19 Pandemic
María Guadalupe Frías-De-León, Rodolfo Pinto-Almazán, Rigoberto Hernández-Castro, Eduardo García-Salazar, Patricia Meza-Meneses, Carmen Rodríguez-Cerdeira, Roberto Arenas, Esther Conde-Cuevas, Gustavo Acosta-Altamirano, Erick Martínez-Herrera
Journal of Fungi.2021; 7(7): 556.     CrossRef
EFFICACY OF ENDOSCOPIC TOPICAL MITOMYCIN C APPLICATION IN CAUSTIC ESOPHAGEAL STRICTURES IN THE PEDIATRIC POPULATION: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
Marcelo Mochate FLOR, Igor Braga RIBEIRO, Diogo Turiani Hourneaux DE MOURA, Sérgio Barbosa MARQUES, Wanderley Marques BERNARDO, Eduardo Guimarães Hourneaux DE MOURA
Arquivos de Gastroenterologia.2021; 58(2): 253.     CrossRef
Coronavirus Disease-Associated Mucormycosis from a Tertiary Care Hospital in India: A Case Series
Yudhyavir Singh, Venkata Ganesh, Shailendra Kumar, Nishant Patel, Richa Aggarwala, Kapil Dev Soni, Anjan Trikha
Cureus.2021;[Epub]     CrossRef
Coronavirus Disease (Covid-19) Associated Mucormycosis (CAM): Case Report and Systematic Review of Literature
Deepak Garg, Valliappan Muthu, Inderpaul Singh Sehgal, Raja Ramachandran, Harsimran Kaur, Ashish Bhalla, Goverdhan D. Puri, Arunaloke Chakrabarti, Ritesh Agarwal
Mycopathologia.2021; 186(2): 289.     CrossRef
Mucormycosis and COVID‐19: An epidemic within a pandemic in India
Lav Selarka, Suktara Sharma, Dinesh Saini, Sanjay Sharma, Amit Batra, Vishal T. Waghmare, Pratibha Dileep, Sanket Patel, Monarch Shah, Tejas Parikh, Prakash Darji, Amit Patel, Gaurav Goswami, Anand Shah, Sandeep Shah, Harsh Lathiya, Moksha Shah, Pranita S
Mycoses.2021; 64(10): 1253.     CrossRef
COVID-19 and mucormycosis superinfection: the perfect storm
Jaffar A. Al-Tawfiq, Saad Alhumaid, Abeer N. Alshukairi, Mohamad-Hani Temsah, Mazin Barry, Abbas Al Mutair, Ali A. Rabaan, Awadh Al-Omari, Raghavendra Tirupathi, Manaf AlQahtani, Salma AlBahrani, Kuldeep Dhama
Infection.2021; 49(5): 833.     CrossRef
COVID-19 Associated Rhino-Orbital Mucormycosis Complicated by Gangrenous and Bone Necrosis—A Case Report from Honduras
Elsa Yolanda Palou, María Auxiliadora Ramos, Emec Cherenfant, Adoni Duarte, Itzel Carolina Fuentes-Barahona, Lysien I. Zambrano, Fausto Muñoz-Lara, Sandra Aracely Montoya-Ramirez, Alex Francisco Cardona-Ortiz, Jorge Alberto Valle-Reconco, Juan J. Monteneg
Vaccines.2021; 9(8): 826.     CrossRef
A rare case of knee joint mucormycosis with pathological fracture after COVID-19 infection
Sergiu Andrei Iordache, Adrian Cursaru, Bogdan Şerban, Mihnea Ioan Gabriel Popa
Romanian Journal of Orthopaedic Surgery and Traumatology.2021; 4(1): 9.     CrossRef
Epidemiology and Pathophysiology of COVID-19-Associated Mucormycosis: India Versus the Rest of the World
Valliappan Muthu, Shivaprakash M. Rudramurthy, Arunaloke Chakrabarti, Ritesh Agarwal
Mycopathologia.2021; 186(6): 739.     CrossRef
COVID-19-associated mucormycosis: Case report and systematic review
Ahmet Dilek, Resat Ozaras, Sevket Ozkaya, Mustafa Sunbul, Elif Itir Sen, Hakan Leblebicioglu
Travel Medicine and Infectious Disease.2021; 44: 102148.     CrossRef
COVID-19 and mucormycosis in Latin America – An emerging concern
Alfonso J. Rodriguez-Morales, Carlos S. Mamani-García, Janeth N. Nuñez-Lupaca, Darwin A. León-Figueroa, Mely Olarte-Durand, Robinson A. Yrene-Cubas, Diana M. Ticona, Sebastian Abanto-Urbano
Travel Medicine and Infectious Disease.2021; 44: 102156.     CrossRef
Overview on the Prevalence of Fungal Infections, Immune Response, and Microbiome Role in COVID-19 Patients
Maryam Roudbary, Sunil Kumar, Awanish Kumar, Lucia Černáková, Fatemeh Nikoomanesh, Célia F. Rodrigues
Journal of Fungi.2021; 7(9): 720.     CrossRef
A case report of rhino-facial mucormycosis in a non-diabetic patient with COVID-19: a systematic review of literature and current update
Faezeh Mohammadi, Milad Badri, Shapoor Safari, Nima Hemmat
BMC Infectious Diseases.2021;[Epub]     CrossRef
Mucormycosis: A manifestation in COVID-19 infection
Abhishek Sharma, Gulnaz Bano, Abdul Malik
Indian Journal of Pharmacy and Pharmacology.2021; 8(3): 189.     CrossRef
A Review of Coronavirus Disease Covid-19
Swapnali Zore
International Journal of Advanced Research in Science, Communication and Technology.2021; : 104.     CrossRef
COVID-19 Associated Mucormycosis: A Systematic Review from Diagnostic Challenges to Management
Farah Yasmin, Hala Najeeb, Aisha Naeem, Kartik Dapke, Rachana Phadke, Muhammad Sohaib Asghar, Syed Muhammad Ismail Shah, Domenico De Berardis, Irfan Ullah
Diseases.2021; 9(4): 65.     CrossRef
COVID-19-Associated Mucormycosis (CAM): An Updated Evidence Mapping
Salman Hussain, Harveen Baxi, Abanoub Riad, Jitka Klugarová, Andrea Pokorná, Simona Slezáková, Radim Líčeník, Abul Kalam Najmi, Miloslav Klugar
International Journal of Environmental Research and Public Health.2021; 18(19): 10340.     CrossRef
Rhino-orbital Mucormycosis as a complication of severe COVID-19 pneumonia
Mohammed A. Alamin, Mohammed Abdulgayoom, Sushil Niraula, Elabbass Abdelmahmuod, Ashraf O. Ahmed, Mohammed I. Danjuma
IDCases.2021; 26: e01293.     CrossRef
COVID-19-Associated Mucormycosis (CAM): Case-Series and Global Analysis of Mortality Risk Factors
Abanoub Riad, Alshaimaa Ahmed Shabaan, Julien Issa, Sally Ibrahim, Hatem Amer, Yossef Mansy, Islam Kassem, Amira Bisher Kassem, Hans-Peter Howaldt, Miloslav Klugar, Sameh Attia
Journal of Fungi.2021; 7(10): 837.     CrossRef
Sinoorbital Mucormycosis Associated with Corticosteroid Therapy in COVID-19 Infection
Zeinab Mehrabi, Maryam Salimi, Kianoush Niknam, Farzaneh Mohammadi, Hesan Jelodari Mamaghani, Mohammad Reza Sasani, Mohammad Javad Ashraf, Amirhossein Salimi, Mohammad Hassan Zahedroozegar, Zohreh Erfani, Huban Atilla
Case Reports in Ophthalmological Medicine.2021; 2021: 1.     CrossRef
Mucormycosis infection in severe COVID‐19 patient with multiple underlying health conditions
Zahra Heydarifard, Moslem Safaei, Sevrin Zadheidar, Soroush Ehsan, Nazanin Zahra Shafiei‐Jandaghi
Clinical Case Reports.2021;[Epub]     CrossRef
Invasive Fungal Infections Complicating COVID-19: A Narrative Review
Giacomo Casalini, Andrea Giacomelli, Annalisa Ridolfo, Cristina Gervasoni, Spinello Antinori
Journal of Fungi.2021; 7(11): 921.     CrossRef
Coronavirus Disease 2019–Associated Invasive Fungal Infection
John W Baddley, George R Thompson, Sharon C -A Chen, P Lewis White, Melissa D Johnson, M Hong Nguyen, Ilan S Schwartz, Andrej Spec, Luis Ostrosky-Zeichner, Brendan R Jackson, Thomas F Patterson, Peter G Pappas
Open Forum Infectious Diseases.2021;[Epub]     CrossRef
Manifestations and risk factors of COVID-19 and mucormycosis: A mini-review
Jugal Sutradhar, BapiRay Sarkar
Journal of Acute Disease.2021; 10(6): 221.     CrossRef
Invasive Mucormycosis – An Enigma
Anil Prasad, Minakshi Mishra, Kaushik Saha
Cureus.2021;[Epub]     CrossRef
Salix spp. Bark Hot Water Extracts Show Antiviral, Antibacterial, and Antioxidant Activities—The Bioactive Properties of 16 Clones
Jenni Tienaho, Dhanik Reshamwala, Tytti Sarjala, Petri Kilpeläinen, Jaana Liimatainen, Jinze Dou, Anneli Viherä-Aarnio, Riikka Linnakoski, Varpu Marjomäki, Tuula Jyske
Frontiers in Bioengineering and Biotechnology.2021;[Epub]     CrossRef
Mucormycosis – resurgence of a deadly opportunist during COVID-19 pandemic: Four case reports
Shalini Upadhyay, Tanisha Bharara, Manisha Khandait, Ankit Chawdhry, Bharat Bhushan Sharma
World Journal of Clinical Cases.2021; 9(36): 11338.     CrossRef
Mucormycosis following COVID19: clinical case and literature review
Sofya N. Khostelidi, V.A. Zaytsev, E.V. Pelikh, E.V. Yashina, O.N. Rodionova, T.S. Bogomolova, Yu.L. Avdeenko, Nikolay N. Klimko
Clinical Microbiology and Antimicrobial Chemotherapy.2021; 23(3): 255.     CrossRef